USPTO serial 88903280
NEUROGIZER
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Dec 7, 2021
- Examiner
- RINKER, ANTHONY MICHAEL
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with NEUROGIZER?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $399*
Plus Government fees of $325
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Purapharm International (H.K.) Limited
Central, HK
Other trademarks owned by Purapharm International (H.K.) Limited
Purapharm International (H.K.) Limited
Central, HK
Other trademarks owned by Purapharm International (H.K.) Limited
Purapharm International (H.K.) Limited
Tai Po, NT, HK
Other trademarks owned by Purapharm International (H.K.) Limited
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Haverly MacArthur
Haverly MacArthur ADAMS AND REESE LLP1600 West End AvenueSuite 1400Nashville, TN 37203Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Nootropics; nootropics containing green tea and lingzhi extracts; green tea extracts for medical purposes for strengthening the immune system and restoring normal bodily functions, the treatment, mitigation and prevention of diseases and disorders, namely, digestive diseases and disorders, obesity, central nervous system diseases and disorders, namely, brain diseases, cognitive disorders, movement disorders, ocular motility, respiratory diseases and disorders, excretory diseases and disorders, cardiovascular diseases and disorders, reproductive diseases and disorders, endocrinal diseases and disorders, immunological diseases and disorders, namely, autoimmune diseases, immunologic deficiency syndrome, hepatitis, dermatological diseases and disorders, skeletal diseases and disorders, namely, bone diseases, back pain, muscular diseases and disorders, namely, muscular dystrophy, inflammatory muscle diseases, sensory diseases and disorders, namely, blindness; green tea extracts for medicinal use; lingzhi extracts for medical purposes for strengthening the immune system and restoring normal bodily functions, the treatment, mitigation and prevention of diseases and disorders, namely, digestive diseases and disorders, obesity, central nervous system diseases and disorders, namely, brain diseases, cognitive disorders, movement disorders, ocular motility, respiratory diseases and disorders, excretory diseases and disorders, cardiovascular diseases and disorders, reproductive diseases and disorders, endocrinal diseases and disorders, immunological diseases and disorders, namely, autoimmune diseases, immunologic deficiency syndrome, hepatitis, dermatological diseases and disorders, skeletal diseases and disorders, namely, bone diseases, back pain, muscular diseases and disorders, namely, muscular dystrophy, inflammatory muscle diseases, sensory diseases and disorders, namely, blindness; lingzhi extracts for medical use; health food supplements; herbal extract in the forms of capsule, tablet, powder and granule; vitamins, vitamin preparations, minerals, enzymes for medical and veterinary purposes; enzyme preparations for medical purposes; dietary and nutritional supplements; nutritional drink mixes in powder form; pharmaceutical and medicinal preparations and substances for strengthening the immune system and restoring normal bodily functions, the treatment, mitigation and prevention of diseases and disorders, namely, digestive diseases and disorders, obesity, central nervous system diseases and disorders, namely, brain diseases, cognitive disorders, movement disorders, ocular motility, respiratory diseases and disorders, excretory diseases and disorders, cardiovascular diseases and disorders, reproductive diseases and disorders, endocrinal diseases and disorders, immunological diseases and disorders, namely, autoimmune diseases, immunologic deficiency syndrome, hepatitis, dermatological diseases and disorders, skeletal diseases and disorders, namely, bone diseases, back pain, muscular diseases and disorders, namely, muscular dystrophy, inflammatory muscle diseases, sensory diseases and disorders, namely, blindness; chemical preparations for medical and pharmaceutical purposes for strengthening the immune system and restoring normal bodily functions, the treatment, mitigation and prevention of diseases and disorders, namely, digestive diseases and disorders, obesity, central nervous system diseases and disorders, namely, brain diseases, cognitive disorders, movement disorders, ocular motility, respiratory diseases and disorders, excretory diseases and disorders, cardiovascular diseases and disorders, reproductive diseases and disorders, endocrinal diseases and disorders, immunological diseases and disorders, namely, autoimmune diseases, immunologic deficiency syndrome, hepatitis, dermatological diseases and disorders, skeletal diseases and disorders, namely, bone diseases, back pain, muscular diseases and disorders, namely, muscular dystrophy, inflammatory muscle diseases, sensory diseases and disorders, namely, blindness; dietetic foods adapted for medical use preparations, dietetic beverages adapted for medical purposes, dietetic foods adapted for medical use substances; dietetic food preparations adapted for medical purposes; digestives for pharmaceutical purposes; medicinal drinks; appetite suppressants; preparations and substances for appetite control and weight management; lip balms for medical purposes; medicated skin lotions for pharmaceutical purposes; analgesics, sedatives, tranquilizers; sunburn ointments, sunburn preparations for pharmaceutical purposes; pharmaceutical preparations for skin care; medicinal mud, mud for baths; mouth washes for medical purposes; medicines for dental purposes; sanitary preparations for medical purposes and for personal hygiene; medicated deodorants other than for personal use, namely, household deodorant; antiseptic shampoos, hair tonic for medical purpose, antiseptic conditioner; veterinary nutritional supplements and medicated grooming preparations for cats, dogs, pets, namely, shampoos, ear wash, ear treatment, soap bars animals; veterinary preparations for cats, dogs, pets for the prevention, diagnosis and treatment of cancer, cardiovascular disease, nervous system diseases, infectious diseases, respiratory diseases, endocrine and metabolic diseases, mental disorder, skin disease, diseases of the blood system, digestive system diseases, immune system diseases, diseases of genitourinary system, ocular diseases, otolaryngology and dentistry diseases, musculoskeletal and connective tissue diseases, nutritional diseases, diseases caused by external factors, namely, poisoning and injury; medicated shampoos for use with animals, food for babies; medical plasters, materials for surgical dressings, namely, gauze; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Purapharm International (H.K.) Limited
- Other trademarks owned by Purapharm International (H.K.) Limited
- Other trademarks owned by Purapharm International (H.K.) Limited
- Other trademarks in Class 005
- Similar marks named NEUROGIZER
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jan 4, 2022 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Jan 4, 2022 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jan 4, 2022 | EWAF | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | — |
| Jan 4, 2022 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 4, 2022 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jan 4, 2022 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Dec 7, 2021 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Nov 2, 2021 | DP1B | 1(B) BASIS DELETED; PROCEED TO REGISTRATION | — |
| Nov 2, 2021 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Oct 19, 2021 | IUCN | NOTICE OF ALLOWANCE CANCELLED | — |
| Oct 19, 2021 | D1BR | TEAS DELETE 1(B) BASIS RECEIVED | — |
| May 25, 2021 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Mar 30, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Mar 30, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 10, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Feb 25, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 1, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 1, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 27, 2021 | ALIE | ASSIGNED TO LIE | — |
| Oct 15, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 6, 2020 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 6, 2020 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 6, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 31, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| May 18, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 9, 2020 | NWAP | NEW APPLICATION ENTERED | — |